GlassScriptPhysician profile
Jan T Hachmann
NPI 1912432212
$3,252.94
in general payments reported to CMS, 2019-2025
11 companies · $2,403 in 2025
The $2,403 reported for 2025 was more than what a typical Neurological Surgery provider received nationally (typical 2025 total: $604).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2024: $850 · 2025: $2,403.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,742 · Travel and Lodging: $511.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,741.54 |
| Travel and Lodging | $511.40 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Clearpoint Neuro, INC. | $682.73 | 2025 | Clearpoint |
| Neuropace, INC. | $656.16 | 2024-2025 | |
| Monteris Medical Corporation | $635.39 | 2024-2025 | Neuroblate |
| Insightec,INC | $455.67 | 2025 | Exablate |
| Medtronic, INC. | $303.89 | 2024-2025 | Percept PC Brainsense |
| Boston Scientific Corporation | $171.63 | 2024-2025 | Vercise, General - Dbs |
| Globus Medical, INC. | $159.69 | 2025 | Excelsius Gps |
| Stryker Corporation | $87.37 | 2025 | Nico Myriad |
| Depuy Synthes Sales INC. | $67.43 | 2025 | Matrixneuro |
| Microtransponder, INC. | $19.20 | 2025 | |
| Integra Lifesciences Corporation | $13.78 | 2025 | Codman Certas, Duraseal Exact Spinal Sealant System, Cusa Clarity |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Jan Hachmann listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.